AI Model can Predict whether Crohn Disease will Recur After Surgery

Using an artificial intelligence (AI) tool that emulates how humans visualize and is trained to recognize and classify images, investigators constructed a model that predicts the postoperative recurrence of Crohn disease with high accuracy by evaluating histological images. The AI tool also revealed previously unrecognized differences in adipose cells and significant differences in the extent of mast cell infiltration in the subserosa, or outer lining of the intestine, comparing patients with and without disease recurrence. The findings appear in The American Journal of Pathology, published by Elsevier.

The 10-year rate of postoperative symptomatic recurrence of Crohn disease, a chronic inflammatory gastrointestinal disease, is estimated at 40%. Although there are scoring systems to evaluate Crohn disease activity and the existence of postoperative recurrence, no scoring system had been developed to predict whether Crohn disease might recur.

"Most of the analysis of histopathological images using AI in the past have targeted malignant tumors," explained lead investigators Takahiro Matsui, MD, PhD, and Eiichi Morii, MD, PhD, Department of Pathology, Osaka University Graduate School of Medicine, Osaka, Japan. "We aimed to obtain clinically useful information for a wider variety of diseases by analyzing histopathology images using AI. We focused on Crohn disease, in which postoperative recurrence is a clinical problem."

Sixty-eight patients with Crohn disease who underwent bowel resection between January 2007 and July 2018 were included in the study. They were classified into two groups according to the presence or absence of postoperative disease recurrence within two years after surgery. Each group was sorted into two subgroups, one for training an AI model and the other for validation. For training, whole slide images of surgical specimens were cropped into tile images, labelled for presence or absence of postsurgical recurrence, and then processed by EfficientNet-b5, a commercially available AI model designed to perform image classification. When the model was tested with unlabeled images, the results indicated that the deep learning model accurately classified the unlabeled images according to the presence or absence of disease occurrence.

Next, predictive heat maps were generated to identify areas and histological features from which the machine learning model could predict recurrence with high accuracy. The images included all layers of the intestinal wall. The heatmaps showed that the machine learning model yielded correct predictions in the subserosal adipose tissue layer. However, in other areas, such as the mucosal and proper muscular layers, the model was less accurate. Images with the most accurate predictions were extracted from the test datasets of the non-recurrence and recurrence groups. Among these images, the best predictive results all contained adipose tissue.

Because the machine learning model achieved accurate predictions from images of subserosal tissue, the investigators hypothesized that subserosal adipose cell morphologies differed between the recurrence and the nonrecurrence groups. Adipose cells in the recurrence group had a significantly smaller cell size, higher flattening, and smaller center to center cell distance values than those in the nonrecurrence group.

"These features, defined as 'adipocyte shrinkage,' are important histological characteristics associated with Crohn disease recurrence," said Dr. Matsui and Dr. Morii.

The investigators also hypothesized that the differences in adipocyte morphology between the two groups were associated with some degree or type of inflammatory condition in the tissue. They found that the recurrence group had a significantly higher number of mast cells infiltrating the subserosal adipose tissue, indicating that the cells are associated with the recurrence of Crohn disease and the "adipocyte shrinkage" phenomenon.

To the investigators' knowledge, these findings are the first to link postoperative recurrence of Crohn disease with the histology of subserosal adipose cells and mast cell infiltration. Dr. Matsui and Dr. Morii observed, "Our findings enable stratification by prognosis of postoperative Crohn disease patients. Many drugs, including biologicals, are used to prevent Crohn disease recurrence, and proper stratification can enable more intensive and successful treatment of high-risk patients."

Kiyokawa H, Abe M, Matsui T, Kurashige M, Ohshima K, Tahara S, Nojima S, Ogino T, Sekido Y, Mizushima T, Morii E.
Deep Learning Analysis of Histologic Images from Intestinal Specimen Reveals Adipocyte Shrinkage and Mast Cell Infiltration to Predict Postoperative Crohn Disease.
Am J Pathol. 2022 Mar 28:S0002-9440(22)00106-7. doi: 10.1016/j.ajpath.2022.03.006

Most Popular Now

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

AI Medical Receptionist Modernizing Doct…

A virtual medical receptionist named "Cassie," developed through research at Texas A&M University, is transforming the way patients interact with health care providers. Cassie is a digital-human assistant created by Humanate...

Using Data and AI to Create Better Healt…

Academic medical centers could transform patient care by adopting principles from learning health systems principles, according to researchers from Weill Cornell Medicine and the University of California, San Diego. In...

Northern Ireland Completes Nationwide Ro…

Go-lives at Western and Southern health and social care trusts mean every pathology service is using the same laboratory information management system; improving efficiency and quality. An ambitious technology project to...

AI Detects Hidden Heart Disease Using Ex…

Mass General Brigham researchers have developed a new AI tool in collaboration with the United States Department of Veterans Affairs (VA) to probe through previously collected CT scans and identify...

AI Tool Set to Transform Characterisatio…

A multinational team of researchers, co-led by the Garvan Institute of Medical Research, has developed and tested a new AI tool to better characterise the diversity of individual cells within...

Human-AI Collectives Make the Most Accur…

Diagnostic errors are among the most serious problems in everyday medical practice. AI systems - especially large language models (LLMs) like ChatGPT-4, Gemini, or Claude 3 - offer new ways...

Highland Marketing Announced as Official…

Highland Marketing has been named, for the second year running, the official communications partner for HETT Show 2025, the UK's leading digital health conference and exhibition. Taking place 7-8 October...

MHP-Net: A Revolutionary AI Model for Ac…

Liver cancer is the sixth most common cancer globally and a leading cause of cancer-related deaths. Accurate segmentation of liver tumors is a crucial step for the management of the...

Groundbreaking TACIT Algorithm Offers Ne…

Researchers at VCU Massey Comprehensive Cancer Center have developed a novel algorithm that could provide a revolutionary tool for determining the best options for patients - both in the treatment...

The Many Ways that AI Enters Rheumatolog…

High-resolution computed tomography (HRCT) is the standard to diagnose and assess progression in interstitial lung disease (ILD), a key feature in systemic sclerosis (SSc). But AI-assisted interpretation has the potential...